[Beta interferon and multiple sclerosis].
Kinnunen
E
E
Department of Neurology, Jyvaskyla Central Hospital, Finland.
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D016899:Interferon-beta / Q000008:administration & dosage*; D008297:Male; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D012008:Recurrence; D012720:Severity of Illness Index; D016896:Treatment Outcome
D016899:Interferon-beta